Does adherence to antiretroviral therapy differ by place of residence in Nigeria? A systematic review and meta-analysis protocol.
HIV & AIDS
public health
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
25 07 2023
25 07 2023
Historique:
medline:
27
7
2023
pubmed:
26
7
2023
entrez:
25
7
2023
Statut:
epublish
Résumé
Retention in care is still a significant challenge in the HIV treatment cascade and varies extensively across regions, leading to poor adherence to antiretroviral therapy (ART). Several factors across different socioecological levels, such as health and community-level factors, inhibit ART adherence among people living with HIV (PLWH) in Nigeria. This review seeks to ask whether adherence to ART differs by place of residence in Nigeria. This systematic review and meta-analysis will follow the updated Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols guidelines. We will search PubMed, SCOPUS, CINAHL, Web of Science, MEDLINE (Ovid) and Google Scholar from onset to 30 April 2023. We will include only quantitative observational studies or mixed-method studies that measured the association between place of residence (urban and rural) and adherence to ART among PLWH aged ≥15 years. Title and abstract screening, full-text screening, data extraction and quality assessment will be done by two reviewers independently. A third reviewer will resolve disagreements. We will extract the author's name and year of publication, study aim(s), participant's characteristics, sample size, sampling method, region and state, adherence definition and adherence level in urban and rural areas. Data will be analysed with Review Manager V.5.4. The Q statistical test will be used to assess between-study heterogeneity, while Higgins and Thompson's I Ethical approval is not warranted for this study since primary published data will be utilised. The findings of this review will be published in a high-impact peer-reviewed journal and presented at a conference. CRD42022371965.
Identifiants
pubmed: 37491090
pii: bmjopen-2022-070024
doi: 10.1136/bmjopen-2022-070024
pmc: PMC10373693
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e070024Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
AIDS Behav. 2021 Dec;25(12):4209-4224
pubmed: 34036459
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Lancet HIV. 2019 Dec;6(12):e809-e811
pubmed: 31439533
Trop Med Infect Dis. 2023 Feb 24;8(3):
pubmed: 36977140
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Clin Infect Dis. 2018 Feb 10;66(5):727-734
pubmed: 29069362
PLoS One. 2022 Jun 15;17(6):e0269252
pubmed: 35704636
PLoS One. 2021 Jan 27;16(1):e0245498
pubmed: 33503050
Front Pharmacol. 2022 Jan 28;12:807446
pubmed: 35153763
AIDS. 2018 May 15;32(8):957-963
pubmed: 29547437
PLoS One. 2022 Jun 8;17(6):e0268892
pubmed: 35675346
Epidemiol Infect. 2018 Apr;146(5):606-611
pubmed: 29486818
PLoS One. 2021 Sep 2;16(9):e0256948
pubmed: 34473774
BMC Public Health. 2022 Mar 4;22(1):440
pubmed: 35246087
BMC Infect Dis. 2018 Jun 8;18(1):266
pubmed: 29879913
IJID Reg. 2022 Apr 28;3:218-225
pubmed: 35755462
J Assoc Nurses AIDS Care. 2022 Jan-Feb 01;33(1):e6-e14
pubmed: 34939992
Healthcare (Basel). 2022 Mar 31;10(4):
pubmed: 35455832
Sci Transl Med. 2017 Mar 29;9(383):
pubmed: 28356504
Pharm Pract (Granada). 2016 Jan-Mar;14(1):631
pubmed: 27011771
J Assoc Nurses AIDS Care. 2023 Jan-Feb 01;34(1):96-104
pubmed: 36198119
Malawi Med J. 2019 Sep;31(3):202-211
pubmed: 31839890
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Front Immunol. 2022 Mar 30;13:844023
pubmed: 35432309